Article

U-M Kellogg Eye Center to be largest in Midwest

The University of Michigan Board of Regents approved a $121-million expansion of the University of Michigan Kellogg Eye Center. The plans include a 222,000-square-foot building that will nearly double the university's current space for eye care, education, and research. This building would be the largest and most comprehensive eye center in the Midwest, according to a University of Michigan release. Completion is scheduled for 2010.

The University of Michigan Board of Regents approved a $121-million expansion of the University of Michigan Kellogg Eye Center. The plans include a 222,000-square-foot building that will nearly double the university's current space for eye care, education, and research. This building would be the largest and most comprehensive eye center in the Midwest, according to a University of Michigan release. Completion is scheduled for 2010.

The new eye center will serve patients with state-of-the-art clinics, educational facilities, and laboratories where scientists will have the resources to accelerate research on eye disease and treatments. Two upper floors of the new eight-floor building will house advanced laboratories for Type 1 diabetes research, and cutting-edge facilities for communications and data sharing among diabetes researchers. The floors will house the offices of the Brehm Center for Type 1 diabetes research and analysis, to honor Delores and William Brehm, who donated $44 million.

New vision research space will also foster programs that can have a direct impact on patient care, including opportunities to collaborate with Brehm researchers on eye-related complications of diabetes. Paul R. Lichter, MD, director of the Kellogg Eye Center, anticipates recruiting new senior scientists to focus on genetic research and other approaches that will lead to rapid development of treatments for age-related macular degeneration and other degenerative eye diseases.

The Kellogg Eye Center has experienced 11% growth in patient visits in each of the past 7 years and expects even faster growth as the aging Baby-Boomer population peaks in the next 10 to 15 years.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.